Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-03-08 | Michelle McMurry-Heath, MD, PhD: Age 53; Principal Occupation: Consultant to Biotechnology Industry. Director of PerkinElmer since July 2022. Member of the audit committee. 2022 Director Compensation: Michelle McMurry-Heath, MD, PhD - Total: $219,160. |
| 2024-03-13 | Michelle McMurry-Heath, MD, PhD: Age 54; Principal Occupation: Consultant to Biotechnology Industry. Director of Revvity since 2022. Member of the audit committee. ... Dr. McMurry-Heath provides the board with strategic leadership experience in working with industry advocacy groups and large biotechnology organizations, as well as collaborating with governmental research organizations and policy makers in an effort to broaden access to scientific progress. ... 2023 Director Compensation ... Michelle McMurry-Heath, MD, PhD Fees Earned or Paid in Cash($) 90,000 Stock Awards($) 200,068 Total ($) 290,068 |
| 2025-03-12 | Founder and Chief Executive Officer, BioTechquity Clinical. |
Data sourced from SEC filings. Last updated: 2025-07-01